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Abstract: Objective: The aim of the research was to determine the dependence of the blood flow 
velocity in the thyroid arteries in patients with autoimmune thyroiditis (AIT) on the presence of 
atherosclerotic carotid disease and the level of systemic blood pressure. 
Method: The research involved 20 patients with AIT in euthyroid state, 30 patients AIT in 
euthyroid state with stable coronary heart disease (CHD), 30 patients with stable CHD and 30 
healthy individuals. Participants of the research were examined using ultrasound of carotid arteries 
and inferior thyroid arteries. Parameters of blood flow velocity were compared with the level of 
systemic blood pressure. 
Results: In AIT peak systolic velocity and resistance index in the inferior thyroid arteries were sig- 
nificantly higher than in healthy individuals and patients with CHD (p<0.05). In patients with CHD 
velocity parameters in carotid arteries were high, unlike in the healthy individuals and patients with 
AIT (p<0.05). In patients with AIT without CHD the atherosclerotic changes of carotid arteries 
were not found. Increased systemic blood pressure was noticed in all patients with CHD without 
significant differences between groups. 
Conclusion: The value of peak systolic velocity and resistance index of inferior thyroid arteries in 
autoimmune thyroiditis are noticed even with euthyroidism and do not depend on systemic blood 
pressure and atherosclerosis of carotid arteries. Increasing the thyroid arterial blood flow velocity 
parameters should be considered as sign of an active inflammatory period AIT, where advanced 
fibrosis is not present. 
Keywords: Autoimmune thyroiditis, atherosclerosis, carotid arteries, thyroid arteries, systemic blood pressure, blood flow ve - 
locity. 
 
1. INTRODUCTION 
Endocrine diseases rank the 4th place in the world in the 
structure of all diseases, most of them are pathologies of the 
thyroid gland (TG) [1]. The prevalence of autoimmune 
thyroiditis (AIT) in Ukraine through the last decade has 
increased by 68 % [2]. The frequency of symptomatic forms 
of AIT is only 1 %. However, AIT is the most common 
cause of hypothyroidism (70-80 %), as chronic autoimmune 
inflammation leads to apoptosis of thyroid cells with 
subsequent fibrosis and loss of functional activity of the TG 
[3]. The abovementioned necessitates the early diagnosis of 
AIT aiming to take active prevention and treatment 
measures. 
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In AIT, in most cases, enhancing thyroid blood flow 
through the blood component is being observed [4]. 
However, we have not found research works, which would 
study dependence of velocity parameters of arterial blood 
flow in the thyroid gland on the structural and functional 
status of the peripheral vasculature, particularly, the presence 
of atherosclerosis (ASVD) of the carotid arteries (CA) and 
blood pressure level (BP), which would provide an 
opportunity to expand understanding of the nature of thyroid 
blood flow changes in AIT and establish the diagnostic value 
of thyroid blood flow parameters as a marker of AIT. 
The aim of our research is to identify the peculiarities of 
dependence of blood flow parameters in the arteries of the 
thyroid gland in patients with autoimmune thyroiditis on the 
structural and functional state of the carotid arteries and 
systemic blood pressure. 
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2. MATERIALS AND METHODS 
An observational study “case-control” has been con- 
ducted. The research involved 110 individuals: 20 patients 
with AIT in euthyroid state (13 women and 7 men aged 
39+5.7), 30 patients (23 women and 7 men aged 54+6.2) 
with AIT in euthyroid state, who had an additional diagnosis 
of coronary heart disease (CHD), stable angina pectoris, FC 
II, Low-to-moderate risk grade 1 hypertension, 30 patients 
with stable CHD and Low-to-moderate risk grade 1 hyper- 
tension (17 men and 13 women aged 57+9.2), and 20 healthy 
individuals (16 women and 14 men aged 34+5.6), amounted 
to the control group. 
Shortly before, every patient signed the informed consent 
to participate in the research, according to the requirements 
of the Declaration of Helsinki of 1975. Ethical, moral and 
legal aspects of conducting the research were agreed with the 
Institutional Review Board of the Higher State Educational 
Establishment of Ukraine “Ukrainian Medical Stomatologi- 
cal Academy”. Diagnosis of AIT was carried out due to the 
standards of European Thyroid Association 2013, diagnosis 
of CHD has been made by coronarography due to the 
recommendations of the European Society of Cardiology 
(ESC) 2013, FC of stable angina pectoris was confirmed by 
the data of ECG treadmill testing, diagnosis of arterial hy- 
pertension was carried out due to the recommendations  of 
the European Society of Hypertension and of the ESC 2013 
[5-7]. The criteria for inclusion into the research were men 
and women`s age of 25-70, euthyroidism, absence of 
destabilizing flow of CHD for at least two months, the 
patient's informed consent to participate in the research and 
his/her willingness to cooperate. Exclusion criteria were: the 
presence of grade 2 and 3 hypertension and high-risk grade 1 
hypertension, class II heart failure, congenital and acquired 
heart disease, rheumatic diseases, anemia, DM and other 
endocrine diseases, chronic liver disease and kidney failure 
function, cancer. 
Ultrasound of TG and CA was being performed on the 
ultrasound scanner “Fukuda UF 750-XT” (Japan) using 
multifrequency linear probe (6.0/7.5/9.0 MHz) in B-mode, 
color Doppler imaging (СDI) and pulsed-wave Doppler 
mode (PWD). 
We determined the thickness of intima-media complex 
(IMC) of common carotid arteries (CCA), according to the 
consensus of the American Society of Echocardiography 
(2008). The measurement of IMC of CCA were being 
performed manually, sequentially in the right and left CCA, 
at a distance of 1 cm from the bifurcation in three projections 
with calculating the average value for each artery [8]. The 
criteria of ASVD of CA were considered to be the IMC 
thickening of 0.9 mm. In the presence of atherosclerotic 
plaques, their nature, size and hemodynamic significance (> 
40 % of CA lumen) were being assessed due to the NASCET 
method: (D - d) / D = % of stenosis, where D is a diameter of 
the internal CA (ICA), d is a diameter of the residual lumen 
of atherosclerotic plaque in CCA [9]. In duplex Doppler 
mode (СDI+PWD) peak systolic velocity (PSV) in CCA was 
being measured. 
Ultrasound of TG was being performed by the standard 
method [10]. In B-mode linear dimensions of thyroid lobes 
were being measured with volume calculation, ultrasound 
characteristics of thyroid tissues were being evaluated. With 
СDI vascularization of parenchyma was being assessed. In 
СDI+PWD peak systolic velocity of blood flow in the infe- 
rior thyroid arteries (IТА) was being measured and, through 
determining diastolic flow velocity (DFV), the resistance index 
(ІR) (Pourcelot index) was being determined by the formula: ІR 
= (PSV – DFV) / PSV [11]. According to the various re- 
searches, blood flow velocity in the superior and inferior 
thyroid arteries is not significantly different and has the same 
dynamics in case of the pathological processes [12]. 
Therefore, we measured the blood flow velocity and derived 
parameters in the right (r) and left (l) ITA only. 
During the ultrasound of CA and TG, the registration of 
blood pressure - systolic (SBP) and diastolic (DBP) ones – 
was held with blood pressure gauge in order to determine its 
possible effect on the studied parameters of blood flow. 
Statistical analysis of the results of the research was be- 
ing carried out using KyPlot program (KyensLab Inc., Ver- 
sion 2.0 beta 15). The hypothesis of normal distribution was 
checked by Shapiro - Wilk test. Belonging to one set of 
samples was verified using Kruskal – Wallis rank test. When 
comparing data among the three and more independent 
groups, unpaired t-Student test with Bonferoni corrections 
and analysis of variance (ANOVA) was used. Data of 
statistical analysis was presented in the form of Х+σ, where 
X was the average value, σ - standard deviation. Differences 
in data were considered to be accurate if the level of 
significance of p-value was <0.05. 
 
3. RESEARCH RESULTS 
Due to the results of ultrasound of TG, in patients with 
АІТ in gray-scale B-mode the reduction or, conversely, the 
relative increase in TG by anteroposterior size was found, or 
the size and volume (V) of the gland stayed unchanged. 33 
% of patients’ thyroids had the shape of a “horseshoe” 
because of the isthmus thickening > 5 mm. Echogenicity of 
thyroid parenchyma in all patients was reduced, echostructure 
was characterized by diffuse heterogeneity due to small 
hypoechoic fuzzy areas of different size, sometimes confluent 
ones, more often - located closer to the front surface of the gland. 
A pronounced stromal component - numerous small linear, 
“punctiform” inclusions in the structure of the gland and 
thickening of the capsule - was detected. In CDI moderate 
diffuse hypervascularization with predominance of the arterial 
component was determined in 85 % of patients with AIT and 
in 86.7 % of patients with CHD combined with AIT. Hy- 
pervascularization was identified by CDI as the diffuse in- 
crease in the number of color signals in parenchyma of TG 
and enlargement of the diameter of the vessels in thyroid 
parenchyma to 3 mm and more [9]. In patients with  CHD 
and in healthy individuals ultrasound evidence of thyroid 
pathology was not found. 
In 41.7 % of patients with CHD and in 53.3 % of patients 
with CHD in combination with AIT atherosclerotic plaques - 
small heterogeneous or echogenic, mostly smooth, less fre- 
quently - irregular, but with no signs of ulceration - were 
detected in CCA and ICA. Hemodynamically, significant 
stenosis of CCA, due to the NASCET method (> 40 %), was 
not found. 
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Table 1. Parameters of blood flow in the inferior thyroid arteries (IТА), common carotid arteries (CCA), intima-media complex 
(IMC) of CCA values and blood pressure levels in patients of research groups 
 
Group / Parameter, Х + σ Group of healthy individuals, n=20 Group CHD, n=30 Group АІТ (euthyroidism), n=20 Group CHD+АІТ, n=30 
V r. lobe, TG, сm3 4.95+1.51 5.42+1.57 5.99+1.58 5.29+1.52 
V l. lobe, TG, сm3 4.35+1.00 4.31+1.02 5.19+1.35 4.65+1.94 
PSV IТА r., m/s 0.17+0.02 0.17+0.03 0.28+0.03* 0.27+0.04*
PSV IТА l., m/s 0.15+0.03 0.17+0.03 0.26+0.03* 0.25+0.04*
IR IТА r., RVU 0.54+0.04 0.55+0.05 0.66+0.04* 0.66+0.04*
IR IТА l., RVU 0.53+0.05 0.54+0.05 0.64+0.04* 0.63+0.03*
PSV CСА r., m/s 0.83+0.12 1.01+0.18*▫ 0.84+0.12 1.04+0.15*▫ 
PSV CСА l., m/s 0.83+0.08 0.98+0.21*▫ 0.81+0.15 1.05+0.18*▫ 
ІМC СА r., mm 0.62+0.08 0.96+0.13*▫ 0.59+0.06 0.94+0.09*▫ 
ІМC СА l., mm 0.65+0.09 0.96+0.06*▫ 0.59+0.05 0.95+0.03*▫ 
SBP, mm Hg 120.43+11.29 143.16+11.21*▫ 123.57+10.08 144.29+8.52*▫ 
DBP, mm Hg 77.40+6.65 89.47+4.68*▫ 78.93+5.25 87.14+6.7*▫ 
Note: * - Significant difference compared with the data of healthy individuals (р<0.05), 
 - Significant difference compared with the data of patients with CHD (р<0.05), 
▫ - Significant difference compared with the data of patients with АІТ (р<0.05). 
 
Fig. (1). Blood flow in the right inferior thyroid artery in the patient with AIT CDI+PWD. 
The results of measurements carried out in the research  
of TG and CA are given in Table 1. According to our data, in 
patients with AIT, as well as in patients with AIT combined 
with CHD, PSV in ITA and IR of ITA were significantly 
higher than in healthy individuals (p<0.05). In patients with 
CHD values of these parameters were not significantly 
different from those in healthy individuals (Table 1, Fig. 1). 
In patients with CHD and CHD in combination with AIT 
increased PSV in CCA and thickened CCA IMC was found, 
unlike in healthy individuals (p<0.05). As shown in Table 1, 
in patients with AIT no changes of parameters characterizing 
the state of CCA were revealed, but the blood flow rates in 
ITA were increased and not significantly different from 
those of patients with AIT combined with CHD (p>0.05). 
Increased systemic blood pressure was noticed only in 
patients with CHD and CHD in combination with AIT 
without reliable differences between groups. 
 
3. DISCUSSION OF THE RESEARCH 
Assessment of arterial blood flow in the thyroid was be- 
ing carried out with determining PSV in CCA, CCA IMC 
along with evaluation of stenosis and systemic BP to detect 
the possible effect of various factors on thyroid blood flow. 
Analysis of the data received showed no causal association 
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of changes in thyroid arterial blood flow and the state of CA 
and systemic BP. Due to AIT, the characteristics of blood 
flow did not depend either on the presence or absence of 
CHD and atherosclerosis of CCA. 
These data indicate that increased blood flow velocity pa- 
rameters (PSV and IR), determined in ITA, are directly asso- 
ciated with pathological processes in the thyroid tissues. 
One of the first researchers, who used ultrasound 
assessment of the thyroid blood flow velocity characteristics 
for verification of pathologies, was Bogazzi F. (1996). He 
found out the fact of increasing the blood flow velocity in 
thyroid arteries with subclinical hypothyroidism and 
hyperthyroidism and determined their limits [13]. 
He and subsequent researchers found that in diffuse toxic 
goiter blood flow velocity in the thyroid arteries increased 
tenfold, which could be an important differential and 
diagnostic sign of that disease and hypertrophic form of AIT, 
along with the defining the level of appropriate antibodies 
[14]. 
From then, the method of ultrasound evaluation of the 
thyroid blood flow velocity characteristics was used by 
certain number of scientists, and they confirmed its 
diagnostic value in AIT, Graves' disease and other thy- 
ropathies. Though, blood flow parameters were compared 
only with hormonal thyroid status [14]. However, either 
hyperthyroidism or subclinical and, in most cases, clinical 
hypothyroidism are accompanied with an increase in thyroid 
blood flow velocity parameters, calling into question the 
conclusion about their dependence on particularly hormone 
activity of the thyroid [15]. 
According to a number of researches, under conditions of 
fibrosis and significant thyroid hypoplasia, thyroid blood 
flow velocity and significant inhibition of its function 
decrease [11, 14]. These structural changes, mainly, are 
consequence of prolonged aggressive course of AIT. Al- 
though, probably, fibrosis does not cause compression or 
stenosis of the thyroid arteries, as blood flow velocity does 
not increase, but, on the contrary, it is reduced, and the 
activity of local inflammatory reactions in this stage of the 
disease is suppressed. 
The patients with AIT and AIT in combination with CHD 
studied had euthyroidism, but the velocity indicators in ITA 
increased. In our opinion, the reason for it might be swelling 
and increased density of thyroid tissue under conditions of 
immune inflammation, or local vasculitis in the presence of 
autoaggression and Th1-cytotoxicity. 
In our previous researches, patients either with AIT or 
with AIT in combination with CHD, along with increased 
levels of proinflammatory cytokines, have revealed an 
increase in the number of circulating microparticles 
CD32
+
CD40
+
 in the blood flow, which characterize the 
inflammatory activation of endothelium [16, 17]. We believe 
it is an immunoinflammatory component that determines the 
velocity increase in thyroid arteries in terms of AIT. There- 
fore, it makes sense to study the relationships of thyroid 
activation with the severity of inflammation in conditions of 
diffuse toxic goiter and other thyroid pathologies to develop 
effective therapeutic strategies in perspective. 
CONCLUSION 
Thus, in AIT PSV increase in ITA on average reaches 48-
65 %, IR increase - 16-20 %. The thyroid arterial blood flow 
velocity parameters increase, regardless of the structural and 
functional status of the peripheral vasculature, non-stenosis 
ASVD CCA on the level of systemic BP in particular. 
Increasing the thyroid arterial blood flow velocity parameters 
should be considered as sign of an active in- flammatory 
period AIT, where advanced fibrosis is not pre- sent. 
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